# OnCo record radotinib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/radotinib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "radotinib" ;
  schema:name "Radotinib"@en ;
  schema:alternateName "Supect"@en ;
  schema:description "Radotinib is an oral kinase inhibitor from Il-Yang Pharm. Co., Ltd., in registered phase 3 trials for chronic myeloid leukaemia."@en ;
  schema:url <https://onco.cc/drugs/radotinib/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=Radotinib> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "Oral kinase inhibitor" ;
  onco:cancers <https://onco.cc/cancers/cml/>, <https://onco.cc/cancers/cml-chronic-phase/> ;
  onco:companies <https://onco.cc/companies/il-yang-pharmaceutical/> ;
  onco:trials <https://onco.cc/trials/nct03722420/>, <https://onco.cc/trials/nct03459534/> .